TNF and sarcoidosis: One previous treatment trial of 343 patients that included questions regarding both fatigue and cognitive concerns showed that patients with sarcoidosis who had a high frequency of cognitive difficulties (i.e., CFQ ≥ 43) also had high fatigue scores, and that both fatigue and perceived cognitive difficulties improved in patients treated with an anti-TNF-α agent [24].